Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects
Clinical trial NCT04129528 · COMPLETED
Trial details
- NCT number
- NCT04129528
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-08
- Primary completion
- 2024-01-15
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.